A Phase 2 trial of sonelokimab in n patients with active PsA.
Latest Information Update: 18 Jan 2025
Price :
$35 *
At a glance
- Drugs Sonelokimab (Primary)
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms P-OLARIS
- 18 Jan 2025 New trial record